-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
LIPELLA PHARMACEUTICALS INC. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2021 to 31 Mar 2025.
- LIPELLA PHARMACEUTICALS INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $1,426,126, a 2.7% decline year-over-year.
- LIPELLA PHARMACEUTICALS INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $3,950,747, a 25% decline from 2023.
- LIPELLA PHARMACEUTICALS INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $3,150,172, a 72% decline from 2022.
- LIPELLA PHARMACEUTICALS INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $1,831,161, a 85% decline from 2021.